Analysis of the tumor microenvironment in ineffective patients of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma

被引：0
|
作者：
Kobayashi, Kazufumi
Ogasawara, Sadahisa
Ishino, Takamasa
Unozawa, Hidemi
Nakagawa, Miyuki
Fujiwara, Kisako
Sakuma, Takafumi
Fujita, Naoto
Kanzaki, Hiroaki
Koroki, Keisuke
Nakamura, Masato
Kiyono, Soichiro
Kanogawa, Naoya
Kondo, Takayuki
Saito, Tomoko
Nakagawa, Ryo
Nakamoto, Shingo
Muroyama, Ryosuke
Chiba, Tetsuhiro
Kato, Naoya
机构：
[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Mol Virol, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.468
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
468
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Tumor microenvironment and clinical efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma
    Taira, Tomonao
    Kojima, Motohiro
    Yamaguchi, Shota
    Inoue, Kanae
    Eguchi, Hiroki
    Okumura, Kei
    Shibuki, Taro
    Satake, Tomoyuki
    Watanabe, Kazuo
    Sasaki, Mitsuhito
    Imaoka, Hiroshi
    Mitsunaga, Shuichi
    Ishii, Genichiro
    Ikeda, Masafumi
    ANNALS OF ONCOLOGY, 2023, 34 : S1399 - S1399
  • [2] Atezolizumab plus bevacizumab for advanced, unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Moris, Dimitrios
    JOURNAL OF BUON, 2021, 26 (02): : 637 - 638
  • [3] Analysis of varix bleeding after Atezolizumab plus Bevacizumab for advanced hepatocellular carcinoma patients
    Lee, Ahlim
    Kim, Hee Yeon
    JOURNAL OF HEPATOLOGY, 2024, 80 : S458 - S458
  • [4] UNRAVELING IMMUNE-ACTIVATED TUMOR MICROENVIRONMENT CORRELATED WITH CLINICAL RESPONSE TO ATEZOLIZUMAB PLUS BEVACIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA
    Goh, MyungJi
    Paik, Yong-Han
    Kang, Wonseok
    Song, Byeonggeun
    Lee, Joon Hyeok
    Choi, Moon Seok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    HEPATOLOGY, 2024, 80
  • [5] Result of atezolizumab plus bevacizumab for advanced or metastatic hepatocellular carcinoma in Vietnamese patients
    Hoang, H. T.
    ANNALS OF ONCOLOGY, 2024, 35 : S88 - S88
  • [6] Efficacy and safety of atezolizumab plus bevacizumab in Korean patients with advanced hepatocellular carcinoma
    Cheon, Jaekyung
    Yoo, Changhoon
    Hong, Jung Yong
    Kim, Han Sang
    Lee, Dae-Won
    Lee, Myung Ah
    Kim, Jin Won
    Kim, Ilhwan
    Oh, Sang-Bo
    Hwang, Jun-Eul
    Chon, Hong Jae
    Lim, Ho Yeong
    LIVER INTERNATIONAL, 2022, 42 (03) : 674 - 681
  • [7] ANALYSIS OF VARIX BLEEDING COMPLICATION AFTER ATEZOLIZUMAB PLUS BEVACIZUMAB FOR ADVANCED HEPATOCELLULAR CARCINOMA PATIENTS
    Kim, Hee
    Lee, Ahlim
    Lee, Sung Won
    Lee, Haelim
    Kwon, Jung Hyun
    Kim, Chang Wook
    Cho, Se Hyun
    Nam, Heechul
    Yang, Hyun
    Song, Do Seon
    Chang, U. Im
    Nam, Soon Woo
    Lee, Soon Kyu
    Kim, Seok-Hwan
    Song, Myeong Jun
    Sung, Pil Soo
    Han, Ji Won
    Jang, Jeong Won
    Bae, Si Hyun
    Choi, Jongyoung
    Yoon, Seung Kew
    HEPATOLOGY, 2024, 80
  • [8] PREDICTING RESPONSE TO ATEZOLIZUMAB PLUS BEVACIZUMAB IN ADVANCED HEPATOCELLULAR CARCINOMA
    Cappuyns, Sarah
    Pique-Gili, Marta
    Esteban-Fabro, Roger
    Philips, Gino
    Pinyol, Roser
    Vandecaveye, Vincent
    Abril-Fornaguera, Jordi
    Haber, Philipp
    Verslype, Chris
    Van Cutsem, Eric
    Lambrechts, Diether
    Villanueva, Augusto
    Dekervel, Jeroen
    Llovet, Josep M.
    HEPATOLOGY, 2023, 78 : S1871 - S1872
  • [9] Association between tumor morphology and efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma
    Ishihara, Nobuaki
    Komatsu, Shohei
    Sofue, Keitaro
    Ueshima, Eisuke
    Yano, Yoshihiko
    Fujishima, Yoshimi
    Ishida, Jun
    Kido, Masahiro
    Gon, Hidetoshi
    Fukushima, Kenji
    Urade, Takeshi
    Yanagimoto, Hiroaki
    Toyama, Hirochika
    Ueda, Yoshihide
    Kodama, Yuzo
    Murakami, Takamichi
    Fukumoto, Takumi
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 773 - 780
  • [10] Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
    Kurebayashi, Yutaka
    Tsujikawa, Hanako
    Sugimoto, Katsutoshi
    Yunaiyama, Daisuke
    Araki, Yoichi
    Saito, Kazuhiro
    Takahashi, Hiroshi
    Kakegawa, Tatsuya
    Wada, Takuya
    Tomita, Yusuke
    Abe, Masakazu
    Yoshimasu, Yu
    Takeuchi, Hirohito
    Hirata, Taiki
    Sakamaki, Kentaro
    Kakimi, Kazuhiro
    Nagao, Toshitaka
    Itoi, Takao
    Sakamoto, Michiie
    HEPATOLOGY RESEARCH, 2023, 53 (10) : 1008 - 1020
12345